Physicochemical Properties
| Molecular Formula | C28H25F2N3OS |
| Molecular Weight | 489.58 |
| Exact Mass | 489.169 |
| CAS # | 120166-69-0 |
| PubChem CID | 657356 |
| Appearance | White to off-white solid powder |
| Density | 1.36g/cm3 |
| Boiling Point | 637.1ºC at 760mmHg |
| Flash Point | 339.1ºC |
| Vapour Pressure | 3.94E-16mmHg at 25°C |
| Index of Refraction | 1.688 |
| LogP | 5.873 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 35 |
| Complexity | 770 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | ZCNBZFRECRPCKU-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C28H25F2N3OS/c29-22-9-5-19(6-10-22)26(20-7-11-23(30)12-8-20)21-13-15-32(16-14-21)17-18-33-27(34)24-3-1-2-4-25(24)31-28(33)35/h1-12H,13-18H2,(H,31,35) |
| Chemical Name | 3-(2-(4-(bis(4-fluorophenyl)methylene)piperidin-1-yl)ethyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one |
| Synonyms | R-59949 R59949 R 59949 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Vasopressin- and collagen-induced release response and aggregation are markedly enhanced in the presence of R59949, which is linked to the production of arachidonic acid metabolites [1]. R59949 restricts the import of CCL2 in THP-1 monocytes. By decreasing the concentration of L-arginine solution across the plasma membrane in vascular smooth muscle cells, R59949 adsorbs the generation of inducible nitric oxide [4]. Half maximal concentration of the Ca2+ signal is 8.6 μM[2]. |
| References |
[1]. The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949. J Biol Chem. 1989;264(6):3274-3285. [2]. Inhibitors of DAG metabolism suppress CCR2 signalling in human monocytes. Br J Pharmacol. 2019;176(15):2736-2749. [3]. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells. Anticancer Drugs. 2002;13(7):725-733. [4]. R59949, a diacylglycerol kinase inhibitor, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol. 2017;390(2):207-214. |
| Additional Infomation | 3-[2-[4-[bis(4-fluorophenyl)methylidene]-1-piperidinyl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one is a diarylmethane. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~204.26 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.11 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0426 mL | 10.2128 mL | 20.4257 mL | |
| 5 mM | 0.4085 mL | 2.0426 mL | 4.0851 mL | |
| 10 mM | 0.2043 mL | 1.0213 mL | 2.0426 mL |